Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Viking Therapeutics, Inc. VKTX

Set alert

Price alert · VKTX

All alert types
26.83 USD -0.45 -1.65%

At close

27.33 +0.50 +1.85%

Pre-market · Nov 3, 4:23 AM ET

Bid
26.82 × 1
Ask
26.83 × 1
26.54 Day range 27.89
23.82 52-week range 43.15
YTD
-23.74%
1 year
-29.54%
Open
27.25
Prev close
27.28
Mkt cap
3.42B
Vol
4.43M
Avg vol
4.79M
EPS
-5.42
P/E
0.00
Div yield
0.00%
More statistics
Low
26.54
High
27.89
Forward P/E
-5.28
Beta
0.75
Short ratio
2.88
Inst. own
60.24%
Dividend
0.00
Ex-div date
Earnings
Feb 10, 2027
50-d avg
30.51
200-d avg
32.40
1y target
95.32

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 7, 2026Rating: Truist Securities · Buy → Buy
Signals (43)
NameDateAgo
SMA: BearishJul 1, 20264 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BearishApr 1, 20267 months ago
SMA: BullishFeb 1, 20269 months ago
SMA: BearishJan 1, 202610 months ago
SMA: BearishNov 1, 20251 year ago
SMA: BullishOct 1, 20251 year ago
SMA: BullishOct 1, 20251 year ago
SMA: BearishFeb 1, 20251 year ago
MACD: Sell SignalDec 1, 20241 year ago
SMA: BearishNov 1, 20242 years ago
RSI: OverboughtOct 1, 20242 years ago
RSI: OverboughtJan 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
MACD: Buy SignalDec 1, 20232 years ago
MACD: Sell SignalNov 1, 20233 years ago
SMA: BearishSep 1, 20233 years ago
RSI: OverboughtFeb 1, 20233 years ago
SMA: BullishDec 1, 20223 years ago
MACD: Buy SignalNov 1, 20224 years ago

Newest 20 of 43.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 95.32 +255.3% upside
Target (low)
34.00
Target (mean)
95.32
Target (high)
125.00
Ratings (0m) 21 19 buy · 2 hold · 0 sell
  • Strong buy5
  • Buy14
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 21
  • 1 month ago 20
  • 2 months ago 20

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

VKTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.35-1.63 – -0.90-1.38+2.4%00.0%17
Next quarter-1.36-1.71 – -1.12-1.37+1.0%00.0%7
Current year-5.31-5.66 – -4.58-3.19-66.4%00.0%16
Next year-5.08-7.29 – -3.40-5.31+4.3%00.0%18

Upgrades and downgrades

The latest rating changes

VKTX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Canaccord GenuityMaintainedBuyBuy
Oct 20, 2026Canaccord GenuityMaintainedBuyBuy
Oct 15, 2026UBSInitiated—Buy
Oct 7, 2026Truist SecuritiesMaintainedBuyBuy
Sep 23, 2026Truist SecuritiesMaintainedBuyBuy
Aug 11, 2026JP MorganMaintainedOverweightOverweight
Jul 30, 2026Canaccord GenuityMaintainedBuyBuy
May 28, 2026Lake StreetInitiated—Buy
May 1, 2026BTIGReiteratedBuyBuy
Apr 30, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Mar 23, 2026HC Wainwright & Co.ReiteratedBuyBuy
Nov 12, 2025Canaccord GenuityMaintainedBuyBuy
Oct 29, 2025Canaccord GenuityInitiated—Buy
Oct 24, 2025JP MorganMaintainedOverweightOverweight
Oct 23, 2025Morgan StanleyMaintainedOverweightOverweight
Sep 29, 2025HC Wainwright & Co.ReiteratedBuyBuy
Sep 22, 2025BTIGReiteratedBuyBuy
Aug 19, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jul 24, 2025Raymond JamesMaintainedStrong BuyStrong Buy
Jul 24, 2025CitigroupMaintainedNeutralNeutral
Jun 25, 2025HC Wainwright & Co.ReiteratedBuyBuy
Apr 28, 2025Cantor FitzgeraldInitiated—Overweight
Apr 28, 2025Truist SecuritiesReiteratedBuyBuy
Apr 24, 2025Morgan StanleyMaintainedOverweightOverweight
Apr 24, 2025HC Wainwright & Co.ReiteratedBuyBuy
Apr 17, 2025HC Wainwright & Co.ReiteratedBuyBuy
Apr 8, 2025Goldman SachsInitiated—Neutral
Mar 26, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 11, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 13, 2025ScotiabankInitiated—Sector Outperform